Sunday, October 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Maintain Neutral Rating on MidAmerica Apartment Communities with Adjusted Price Targets

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Real Estate Investment Markets and money
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analyst Vikram Malhotra from Mizuho has decided to keep a Neutral rating on Mid-America Apartment Communities (NYSE: MAA) but has adjusted the price target to $126 from $132. This change comes after a series of price target adjustments by various analysts, with an average hold rating and price target range of $124 to $158 according to Capital IQ. Linda Tsai from Jefferies also joined in on the discussion, lowering the price target to $124.
These updates suggest a cautious approach towards Mid-America Apartment Communities’ stock performance, indicating a shift in sentiment among analysts.

MAA Stock Shows Positive Momentum with 0.96% Increase – Investors Advised to Proceed with Caution

On February 28, 2024, MAA stock showed some positive momentum as it closed the day with a 0.96% increase in its share price. The stock closed at $124.89, which was $1.19 higher than the previous close. Additionally, in after-hours trading, MAA continued to rise, with the stock increasing by $0.43.

Investors should keep an eye on MAA in the coming days to see if the positive momentum continues. It will be important to monitor whether the stock can break through its 200-day moving average and start trending upwards. Additionally, any news or developments related to the company could also impact the stock’s performance.

Overall, while MAA may have shown some positive movement on February 28th, investors should approach the stock with caution and conduct thorough research before making any investment decisions.

MAA Stock Performance Analysis: Revenue Growth but Net Income Decline

On February 28, 2024, MAA stock had mixed performances based on the financial data provided by CNN Money. The total revenue for MAA stood at $2.15 billion for the past year, with a quarterly revenue of $542.25 million. The total revenue increased by 6.37% compared to the previous year but remained flat since the last quarter.

The net income for MAA was reported at $552.58 million for the past year, with a quarterly net income of $160.41 million. The net income decreased by 13.25% since the previous year but saw a significant increase of 44.92% since the last quarter.

The earnings per share (EPS) for MAA were $4.71 for the past year and $1.36 for the last quarter. The EPS decreased by 14.18% compared to the previous year but increased by 45.12% since the last quarter.

Overall, MAA stock showed a mix of positive and negative performances on February 28, 2024. The increase in total revenue since last year indicates growth in the company’s top line, while the decrease in net income and EPS compared to the previous year may raise some concerns among investors. However, the significant increase in net income and EPS since the last quarter could be seen as a positive sign for the company’s financial health in the short term.

Tags: MAA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Assets (2)

Ambarellas Stock Soars After Exceeding Expectations in Q4 FY24

Finance_Banking (2)

Analyst Updates Rating on Array Technologies to Neutral

AI medical laboratory

Crinetics Pharmaceuticals Secures 350 Million in Private Placement Financing

Recommended

American Express Stock

American Express Charts Digital Future with Blockchain and Premium Partnerships

3 days ago
Xcel Energy Stock

Xcel Energy Bets Big with $45 Billion Infrastructure Overhaul

3 weeks ago
Airbus Stock

Airbus Stock: Strategic Wins Reshape Aerospace Leadership

1 month ago
Healthcare cloud based

Wedbush Analyst Maintains Neutral Rating on Regenxbio with 21 Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Sonoma Pharmaceuticals Shares Experience Dramatic Trading Session

Fuel Cell Surge: Bloom Energy Stock Soars on Massive AI Power Project

Can Copart Stock Overcome Market Indifference?

A Precipitous Fall for Vintage Wine Estates

Institutional Investors Signal Caution on Take-Two Shares

Super Micro Stock Faces Fifth Consecutive Earnings Shortfall

Trending

Super League Gaming Inc Stock
Gaming & Metaverse

A Pivotal Week for Super League Gaming’s Strategic Trajectory

by Robert Sasse
October 5, 2025
0

Super League Enterprise (Nasdaq: SLGG) is approaching a potentially transformative period, underscored by its upcoming participation in...

Medical Properties Stock

Is Medical Properties Trust Mounting a Sustainable Recovery?

October 5, 2025
Synthetic Biolog.dl -,001 Stock

Theriva Biologics Faces Critical Juncture Following Deep Workforce Cuts

October 5, 2025
Sonoma Pharmaceuticals Stock

Sonoma Pharmaceuticals Shares Experience Dramatic Trading Session

October 5, 2025
Bloom Energy Stock

Fuel Cell Surge: Bloom Energy Stock Soars on Massive AI Power Project

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • A Pivotal Week for Super League Gaming’s Strategic Trajectory
  • Is Medical Properties Trust Mounting a Sustainable Recovery?
  • Theriva Biologics Faces Critical Juncture Following Deep Workforce Cuts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com